# A Phase 4 Study Investigating the Efficacy of Retaine™ in Managing Signs and Symptoms Associated With Dry Eye Syndrome

> **NCT02139033** · PHASE4 · COMPLETED · sponsor: **Ocusoft, Inc.** · enrollment: 42 (actual)

## Conditions studied

- Keratoconjunctivitis Sicca

## Interventions

- **DRUG:** Retaine™

## Key facts

- **NCT ID:** NCT02139033
- **Lead sponsor:** Ocusoft, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2014-06-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02139033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02139033, "A Phase 4 Study Investigating the Efficacy of Retaine™ in Managing Signs and Symptoms Associated With Dry Eye Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02139033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*